Danielle Edwards

Danielle is a staff writer with INN. She graduated from the Master of Journalism program at Carleton University after completing her undergraduate degree in Media Studies at the University of Guelph-Humber. She's written for the Globe and Mail, the Canadian Press, the National Post and the Brampton Guardian. She spends her time covering the cannabis market for INN.



Distressed Debt Becoming Key Cannabis Strategy, Expert Says

Distressed debt lenders see the beleaguered cannabis market as attractive right now, but investors may want to be wary of...

February 27th, 2020

Developers Create Coronavirus-backed Crypto Token

The token is the “world’s first crypto backed by proof of death,” rising in value every time a person is...

February 27th, 2020

EY: Outlook for 5G Rosy Despite Current Challenges

Companies are recognizing the benefits of 5G systems, but issues surrounding budget pressure and concerns about relevance are challenges to...

February 27th, 2020

Ultragenyx, Kyowa Kirin Announce FDA Acceptance for Supplemental Biologics License

Ultragenyx and Kyowa Kirin announced that the FDA has accepted for review the supplemental Biologics License Application for Crysvita for...

February 27th, 2020

Intellia Announces Q4 and Full-Year 2019 Financial Results

Intellia Therapeutics reported operational highlights and financial results for the fourth quarter and year ended December 31, 2019.

February 27th, 2020

CloudMD Scales Up Telemedicine Availability Amidst COVID-19 Outbreak

CloudMD Software & Services has provided an update on its telemedicine app amidst the global coronavirus outbreak.

February 27th, 2020

FLIR Announces Fourth Quarter and Full Year 2019 Financial Results

FLIR Systems announced financial results for the fourth quarter and full year ended December 31, 2019.

February 27th, 2020